Surgery Websites
Department of Surgery »  Faculty »  General Surgery »  Rita Mukhtar, M.D.
Rita Mukhtar, M.D.

Rita Mukhtar, M.D.

Assistant Professor of Surgery
Division of General Surgery

Contact Information

Open Popup
  • 1996-2000 University of California, Berkeley, AB Molecular and Cell Biology
  • 2001-2006 University of California, San Francisco, MD
  • 2006-2012 University of California, San Francisco, Resident, General Surgery
  • 2012-2013 University of California, San Francisco, Chief Resident, General Surgery
  • 2009-2011 University of California, San Francisco, Post-doctoral Research Fellow
  • 2013-2014 University of California, San Francisco, Society of Surgical Oncology Fellow, Breast Surgery
  • 2009-2010 UCSF CTSI Advanced Training in Clinical Research
  • American Board of Surgery, General Surgery
  • Carol Franc Buck Breast Care Center

Rita Mukhtar, M.D. is a General and Breast Oncologic Surgeon at UCSF. Dr Mukhtar completed her undergraduate education at UC Berkeley, where she studied music and molecular biology. She then attended medical school at UCSF, during which time she received a Doris Duke Clinical Research Fellowship and pursued research in the inflammatory response in sepsis, winning a resident research award. She remained at UCSF for General Surgery residency, and completed a two year post-doctoral research fellowship focusing on the role of inflammatory cells in breast cancer outcomes, funded by the California Breast Cancer Research Program.

During this time she received a scholarship from the UCSF Clinical and Translational Science Institute to complete a certificate in Advanced Training in Clinical Research. After residency, she completed a fellowship in breast oncologic surgery, while serving as a clinical instructor in general surgery. She currently practices acute care general surgery and breast surgery, including treatment of benign and malignant breast disease. Her research interest is in genetic causes of breast cancer, prevention, and treatment.

Most recent publications from a total of 19
  1. Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, Esserman L, Mukhtar R, Finlayson E. Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents. JAMA Surg. 2018 Aug 29. View in PubMed
  2. Mukhtar RA. ASO Author Reflections: Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients. Ann Surg Oncol. 2018 Aug 27. View in PubMed
  3. Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2018; 4:26. View in PubMed
  4. Mukhtar RA, Wong J, Piper M, Zhu Z, Fahrner-Scott K, Mamounas M, Sbitany H, Alvarado M, Foster R, Ewing C, Esserman L. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients. Ann Surg Oncol. 2018 Jul 27. View in PubMed
  5. Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2017 01; 161(1):17-28. View in PubMed
  6. Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases. 2015 Jul 16; 3(7):607-13. View in PubMed
  7. Mukhtar RA, Wong JM, Esserman LJ. Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care. J Natl Compr Canc Netw. 2015 Jun; 13(6):737-43. View in PubMed
  8. Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013; 8(10):e79114. View in PubMed
  9. Mukhtar RA, Yau C, Rosen M, Tandon VJ. Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol. 2013 Nov; 20(12):3823-30. View in PubMed
  10. Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(1):35-43. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Rita Mukhtar, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

Site Directory
    X